News archive

February 6, 2023
Sensor longevity breakthrough in Lifecare Ongoing clinical development study confirms Lifecare’s expectation of a sensor longevity that far exceeds the lifetime of existing and commercially available needle sensors for glucose monitoring.   CSO Prof. Andreas Pfützner and CEO Joacim Holter   Today Lifecare can report that sensors used in a three-day clinical study continue to […]
Read more
January 26, 2023
New collaboration strengthens Lifecare’s development Lifecare recently entered into a partnership with Goethe University Frankfurt am Main.   – Complementary expertise, further strengthening of our product development as well as strengthening our potential recruitment base were decisive for the new agreement with a professionally strong research environment, says CEO Joacim Holter. CEO Joacim Holter and CSO […]
Read more
January 5, 2023
2022 was a very good year for Lifecare as a company and we welcome 2023 expecting continued significant progress in our mission to make life easier for patients with diabetes.    Joacim Holter, CEO at Lifecare    Throughout 2022 Lifecare reached several milestone events:     In June, Lifecare disclosed the by far most important development events […]
Read more
December 6, 2022
Lifecare announces all-time high revenue in their financial reporting for Q3 2022. – We are pleased to see a positive outcome of the investments we have made. Furthermore, this provides a base for Lifecare´s continued research and product development, says CEO Joacim Holter.    Joacim Holter, CEO at Lifecare   The consolidated group financials show […]
Read more
December 1, 2022
Q3 financial and operational update Lifecare AS will present Q3 2022 financial and operational status on Tuesday 6 December.   The webcast will be for all shareholders and interested parties at 13:00 – 14:00 CET. Lifecare CEO Joacim Holter will participate in the webcast. There will be a Q&A session following the presentation. The webcast will be available […]
Read more
November 8, 2022
Lifecare has incorporated a new subsidiary, Lifecare Chemistry Ltd, located in Bath, UK. – This move gives us clear strategic advantages related to chemical research development and builds on the close and good collaboration Lifecare already has established with the University of Bath, says CEO Joacim Holter.   Photo caption: Left to right: Jordan Gardiner, […]
Read more
October 7, 2022
Business presentation at LSX 2022 The LSX Nordic Congress is the leading senior executive strategy, investment and partnering conference for the Nordic region and took place in Copenhagen in September. – We register an increasing interest for the company on the Nordic investor scene, states CEO Joacim Holter.   – After a long period of pandemic, […]
Read more
October 4, 2022
Interim data analysis of the first in-human study shows that Lifecare’s sensor is able to monitor glucose variations. Conducting clinical trials on humans is a significant step towards Lifecare’s goal of contributing to helping people with diabetes to live a normal life.     The purpose of the first study is to optimize signal reading from the […]
Read more
August 8, 2022
Independent experts from the European Commission’s Innovation Radar have reviewed Lifecares technology in the EU funded project FORGETDIABETES. The review concludes that Lifecare’s innovations are “Market Ready” and considered among the top 14% of innovations in scientific projects receiving financial grants from the European Commission.   Lifecare is part of the EU funded research project […]
Read more
July 4, 2022
Lifecare achieved the two major milestones for 1H2022 in June and continue to strengthen the organization. It was a very important milestone for Lifecare to conclude successful, high-quality and reproduceable in-vitro test results with the fabricated Sencell sensor prototypes for the clinical trials on 2 June 2022: https://newsweb.oslobors.no/message/563975 Following this achievement, Lifecare continued the prototype […]
Read more